4.7 Editorial Material

Donohue Syndrome

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 97, Issue 5, Pages 1416-1417

Publisher

ENDOCRINE SOC
DOI: 10.1210/jc.2011-3215

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance

Isabel Huang-Doran, Alexandra B. Kinzer, Mercedes Jimenez-Linan, Kerrie Thackray, Julie Harris, Claire L. Adams, Marc de Kerdanet, Anna Stears, Stephen O'Rahilly, David B. Savage, Phillip Gorden, Rebecca J. Brown, Robert K. Semple

Summary: Severe insulin resistance (IR) is associated with high levels of androgens and ovarian changes similar to polycystic ovary syndrome (PCOS). Treatment with GnRH analogues can improve hyperandrogenic symptoms and reduce testosterone levels in different subtypes of SIR. Insulin signaling disorders and adipose development defects have distinct relationships with free testosterone levels, mediated by sex hormone-binding globulin (SHBG).

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Review Genetics & Heredity

A standard of care for individuals with PIK3CA-related disorders: An international expert consensus statement

Sofia Douzgou, Myfanwy Rawson, Eulalia Baselga, Moise Danielpour, Laurence Faivre, Alon Kashanian, Kim M. Keppler-Noreuil, Paul Kuentz, Grazia M. S. Mancini, Marie-Cecile Maniere, Victor Martinez-Glez, Victoria E. Parker, Robert K. Semple, Siddharth Srivastava, Pierre Vabres, Marie-Claire Y. De Wit, John M. Graham, Jill Clayton-Smith, Ghayda M. Mirzaa, Leslie G. Biesecker

Summary: Growth promoting variants in PIK3CA can cause a range of developmental disorders, grouped as PIK3CA-Related Overgrowth Spectrum disorders (PROS). Managing these conditions presents challenges due to clinical heterogeneity and lack of medical expertise in affected families. A consensus on management guidelines is needed to address these issues effectively.

CLINICAL GENETICS (2022)

Correction Genetics & Heredity

Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities (Apr, 10.1038/s41436-021-01161-6, 2021)

Virginie Carmignac, Cyril Mignot, Emmanuelle Blanchard, Paul Kuentz, Marie-Helene Aubriot-Lorton, Victoria E. R. Parker, Arthur Sorlin, Sylvie Fraitag, Jean-Benoit Courcet, Yannis Duffourd, Diana Rodriguez, Rachel G. Knox, Satyamaanasa Polubothu, Anne Boland, Robert Olaso, Marc Delepine, Veronique Darmency, Melissa Riachi, Chloe Quelin, Paul Rollier, Louise Goujon, Sarah Grotto, Yline Capri, Marie-Line Jacquemont, Sylvie Odent, Daniel Amram, Martin Chevarin, Catherine Vincent-Delorme, Benoit Catteau, Laurent Guibaud, Alexis Arzimanoglou, Malika Keddar, Catherine Sarret, Patrick Callier, Didier Bessis, David Genevieve, Jean-Francois Deleuze, Christel Thauvin, Robert K. Semple, Christophe Philippe, Jean-Baptiste Riviere, Veronica A. Kinsler, Laurence Faivre, Pierre Vabres

GENETICS IN MEDICINE (2021)

Review Endocrinology & Metabolism

Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes

Amelie Bonnefond, Robert K. Semple

Summary: Integration of genomic and other data has stratified type 2 diabetes, but has not yet impacted mainstream diabetes practice. Diabetes caused by single gene defects provides the best example of precision diabetes, with clear genotype-selective responses to therapy. In monogenic insulin-resistant diabetes, subcutaneous leptin therapy benefits severe lipodystrophy patients. The main challenge in beta cell diabetes is the implementation of precision diabetes vision at scale. While genotype-specific benefits for monogenic insulin-resistant diabetes have been proven in fewer patients, further genotype-targeted therapies are being evaluated.

DIABETOLOGIA (2022)

Editorial Material Biochemistry & Molecular Biology

PIK3CA-related overgrowth: silver bullets from the cancer arsenal?

Ralitsa R. Madsen, Robert K. Semple

Summary: Mutations that activate growth factor signaling play a crucial role in cancer growth, but they can also cause developmental growth disorders when they occur in isolation. PIK3CA, a gene that encodes a catalytic subunit of phosphatidylinositol 3-kinase (PI3K), exemplifies this paradigm. This article discusses the recent exciting progress towards repurposing cancer drugs for PIK3CA-driven overgrowth, which is a key goal in cancer research.

TRENDS IN MOLECULAR MEDICINE (2022)

Editorial Material Endocrinology & Metabolism

Insulin Resistance and Adrenal Androgen Synthesis Viewed Through a Monogenic Lens

Robert K. Semple

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Pharmacology & Pharmacy

Partial lipodystrophy, severe dyslipidaemia and insulin resistant diabetes as early signs of Werner syndrome

Isis Atallah, Dominique McCormick, Jean-Marc Good, Mohammed Barigou, Montserrat Fraga, Christine Sempoux, Andrea Superti-Furga, Robert K. Semple, Christel Tran

Summary: This article describes a case of Werner syndrome presenting with early onset diabetes, partial lipodystrophy, severe dyslipidaemia, and rapidly progressive liver fibrosis. Molecular diagnosis revealed compound heterozygous mutations in the WRN gene. The study suggests that including WRN gene analysis in patients with early onset diabetes, lipodystrophy, or dyslipidaemia can allow for early detection of Werner syndrome and implementation of preventive interventions.

JOURNAL OF CLINICAL LIPIDOLOGY (2022)

Article Endocrinology & Metabolism

Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Cambridge, UK, 7-8 April 2022

Helena Mosbah, Baris Akinci, David Araujo-Vilar, Juan Carrion Tudela, Giovanni Ceccarini, Philippe Collas, I. Sadaf Farooqi, Antia Fernandez-Pombo, Isabelle Jeru, Fredrik Karpe, Kerstin Krause, Margherita Maffei, Konstanze Miehle, Elif Oral, Naca Perez de Tudela, Xavier Prieur, Justin Rochford, Rebecca Sanders, Ferruccio Santini, David B. Savage, Julia von Schnurbein, Robert Semple, Anna Stears, Ekaterina Sorkina, Marie-Christine Vantyghem, Camille Vatier, Antonio Vidal-Puig, Corinne Vigouroux, Martin Wabitsch

Summary: Lipodystrophy syndromes are rare diseases that affect the development or maintenance of adipose tissue, leading to severe metabolic complications. The European Consortium of Lipodystrophies (ECLip) is a non-profit network that promotes scientific understanding and clinical management of these diseases through collaborations and a patient registry.

ANNALES D ENDOCRINOLOGIE (2022)

Article Immunology

Ethnic differences in complement system biomarkers and their association with metabolic health in men of Black African and White European ethnicity

L. M. Goff, K. Davies, W. M. Zelek, E. Kodosaki, O. Hakim, S. Lockhart, S. O'Rahilly, B. P. Morgan

Summary: Poor metabolic health and obesity in Black African populations contribute to increased susceptibility to disease, including COVID-19. Complement dysregulation has been linked to metabolic health and implicated as a driver of pathology; however, ethnic differences in complement have not been explored.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

p53 Regulates Mitochondrial Dynamics in Vascular Smooth Muscle Cell Calcification

Kanchan Phadwal, Qi-Yu Tang, Ineke Luijten, Jin-Feng Zhao, Brendan Corcoran, Robert K. Semple, Ian G. Ganley, Vicky E. MacRae

Summary: Arterial calcification, a characteristic of cardiovascular disease, shares similarities with skeletal mineralization but the cellular mechanisms are not fully understood. This study found that vascular smooth muscle cell (VSMC) calcification is associated with elongated mitochondria, increased reactive oxygen species production, and reduced mitophagy. The protein expressions of OPA1 and DRP1, key regulators of mitochondrial fusion and fission, respectively, were also altered. Additionally, p53-induced mitochondrial fusion was found to underlie cellular senescence in VSMC calcification.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Endocrinology & Metabolism

Prevalence of Deleterious Variants in MC3R in Patients With Constitutional Delay of Growth and Puberty

Katie Duckett, Alice Williamson, John W. R. Kincaid, Kara Rainbow, Laura J. Corbin, Hilary C. Martin, Ruth Y. Eberhardt, Qin Qin Huang, Matthew E. Hurles, Wen He, Raja Brauner, Angela Delaney, Leo Dunkel, Romina P. Grinspon, Janet E. Hall, Joel N. Hirschhorn, Sasha R. Howard, Ana C. Latronico, Alexander A. L. Jorge, Ken McElreavey, Veronica Mericq, Paulina M. Merino, Mark R. Palmert, Lacey Plummer, Rodolfo A. Rey, Raissa C. Rezende, Stephanie B. Seminara, Kathryn Salnikov, Indraneel Banerjee, Brian Y. H. Lam, John R. B. Perry, Nicholas J. Timpson, Peter Clayton, Yee-Ming Chan, Ken K. Ong, Stephen O'Rahilly

Summary: Deleterious variants in MC3R are more frequently found in patients with constitutional delay of growth and puberty (CDGP) compared to normosmic idiopathic hypogonadotropic hypogonadism (nIHH). However, these variants are not a common cause of CDGP.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Endocrinology & Metabolism

Resolution of dysglycaemia after treatment of monoclonal gammopathy of endocrine significance

Bonnie Grant, Gowri Ratnayake, Claire L. Williams, Anna Long, David J. Halsall, Robert K. Semple, James D. Cavenagh, William M. Drake, David S. Church

Summary: This case report describes a 67-year-old man with monoclonal gammopathy who developed disabling hypoglycaemia due to an insulin-binding paraprotein. Despite distal pancreatectomy, his symptoms persisted, but were successfully managed with plasma exchange and Lenalidomide treatment.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2023)

Meeting Abstract Oncology

Functional dissection of GNAQ and GNA11 oncogenic mutations identifies potential targeted therapy

Davide Zecchin, Nicole Knoepfel, Anna Gluck, Mark Stevenson, Kate E. Lines, Satyamaanasa Polubothu, Noreen Muwanga-Nanyonjo, Sara Barberan-Martin, Fanourios Michailidis, Dale Bryant, Ulrike Loebel, Asuka Inoue, Robert Semple, Sarah Aylett, Rajesh V. Thakker, Veronica A. Kinsler

CANCER RESEARCH (2022)

Meeting Abstract Dermatology

Aberrant calcium signalling and systemic hypocalcaemia in GNAQ/11 mosaic diseases

Davide Zecchin, Nicole Knoepfel, Anne Gluck, Mark Stevenson, Satyamaanasa Polubothu, Noreen Muwanga-Nanyonjo, Sara Barberan-Martin, Fanis Michailidis, Dale Bryant, Ulrike Loebel, Hanna Richardson, Sarah Aylett, Martin Tisdall, Asuka Inoue, Robert Semple, Rajesh Thakker, Veronica Kinsler

BRITISH JOURNAL OF DERMATOLOGY (2022)

No Data Available